Prediction of genotoxicity of chemical compounds by statistical learning methods

Chemical Research in Toxicology

Volumn 18, Issue 6, 2005, Pages 1071-1080

  Li, H ^a   Ung, C Y ^a   Yap, C W ^a   Xue, Y ^a,b   Li, Z R ^a,b   Cao, Z W ^c   Chen, Y Z ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SICHUAN UNIVERSITY   (China)

^c SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; TOXIC SUBSTANCE;

ACCURACY; ARTICLE; ARTIFICIAL NEURAL NETWORK; DEVICE; GENOTOXICITY; MOLECULAR DYNAMICS; MOLECULAR IMAGING; PREDICTION; STATISTICAL ANALYSIS;

COMPUTATIONAL BIOLOGY; DECISION SUPPORT TECHNIQUES; DRUG EVALUATION, PRECLINICAL; MUTAGENS; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS;

EID: 21144435586     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049652h     Document Type: Article

References (63)

1. Johnson, D. E., and Wolfgang, G. H. (2000) Predicting human safety: Screening and computational approaches. Drug Discovery Today 5, 445-454.
2. van de Waterbeemd, H., and Gifford, E. (2003) ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discovery 2, 192-204.
3. Kennedy, T. (1997) Managing the drug discovery/development interface. Drug Discovery Today 2, 436-444.
4. Bolzan, A. D., and Bianchi, M. S. (2002) Genotoxicity of streptozotocin. Mutat. Res. 512, 121-134.
5. Snyder, R. D., Pearl, G. S., Mandakas, G., Choy, W. N., Goodsaid, F., and Rosenblum, I. Y. (2004) Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules. Environ. Mol. Mutagen. 43, 143-158.
6. Kramer, P. J. (1998) Genetic toxicology. J. Pharm. Pharmacol. 50, 395-405.
7. Schwetz, B. A., and Casciano, D. A. (1998) Genetic toxicology: Impact on the next generation of toxicology. Environ. Mol. Mutagen. 31, 1-3.
8. Greene, N. (2002) Computer systems for the prediction of toxicity: An update. Adv. Drug Delivery Rev. 54, 417-431.
9. Cash, G. G. (2001) Prediction of the genotoxicity of aromatic and heteroaromatic amines using electrotopological state indices. Mutat. Res. 491, 31-37.
10. Marchant, C. A. (1996) Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program. The DEREK Collaborative Group. Environ. Health Perspect. 104, 1065-1073.
11. Mosier, P. D., Jurs, P. C., Custer, L. L., Durham, S. K., and Pearl, G. M. (2003) Predicting the genotoxicity of thiophene derivatives from molecular structure. Chem. Res. Toxicol. 16, 721-732.
12. He, L., Jurs, P. C., Custer, L. L., Durham, S. K, and Pearl, G. M. (2003) Predicting the genotoxicity of polycyclic aromatic compounds from molecular structure with different classifiers. Chem. Res. Toxicol. 16, 1567-1580.
13. Mattioni, B. E., Kauffman, G. W., Jurs, P. C., Custer, L. L., Durham, S. K, and Pearl, G. M. (2003) Predicting the genotoxicity of secondary and aromatic amines using data subsetting to generate a model ensemble. J. Chem. Inf. Comput. Sci. 43, 949-963.
14. Cristianini, N., and Shawe-Taylor, J. (2000) An Introduction to Support Vector Machines and Other Kernel-Based Learning Methods, Cambridge University Press, New York.
15. Surges, C. J. C. (1998) A tutorial on support vector machines for pattern recognition. Data Min. Knowledge Discovery 2, 127-167.
16. Quinlan, J. R. (1993) C4.5: Programs for Machine Learning, Morgan Kaufmann, San Mateo, CA.
17. Specht, D. F. (1990) Probabilistic neural networks. Neural Networks 3, 109-118.
18. Johnson, R. A., and Wichern, D. W. (1982) Applied Multivariate Statistical Analysis, Prentice Hall, Englewood Cliffs, NJ.
19. Doniger, S., Hofman, T., and Yeh, J. (2002) Predicting CNS permeability of drug molecules: Comparison of neural network and support vector machine algorithms. J. Comput. Biol. 9, 849-864.
20. Trotter, M. W. B., Buxton, B. F., and Holden, S. B. (2001) Support vector machines in combinatorial chemistry. Meas. Control 34, 235-239.
21. Furey, T. S., Cristianini, N., Duffy, N., Bednarski, D. W., Schummer, M., and Haussler, D. (2000) Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16, 906-914.
22. Bock, J. R., and Gough, D. A. (2001) Predicting protein-protein interactions from primary structure. Bioinformatics 17, 455-460.
23. Serra, J. R., Thompson, E. D., and Jurs, P. C. (2003) Development of binary classification of structural chromosome aberrations for a diverse set of organic compounds from molecular structure. Chem. Res. Toxicol. 16, 153-163.
24. Yap, C. W., Cai, C. Z., Xue, Y., and Chen, Y. Z. (2004) Prediction of torsade-causing potential of drugs by support vector machine approach. Toxicol. Sci. 79, 170-177.
25. Xue, Y., Yap, C. W., Sun, L. Z., Cao, Z. W., Wang, J. F., and Chen, Y. Z. (2004) Prediction of p-glycoprotein substrates by support vector machine approach. J. Chem. Inf. Comput. Sci. 44, 1497-1505.
26. Burbidge, R., Trotter, M., Buxton, B., and Holden, S. (2001) Drug design by machine learning: Support vector machines for pharmaceutical data analysis. Comput. Chem. 26, 5-14.
27. Czerminski, R., Yasri, A., and Hartsough, D. (2001) Use of support vector machine in pattern classification: Application to QSAR studies. Quant. Struct.-Act. Relat. 20, 227-240.
28. Yu, H., Yang, J., Wang, W., and Han, J. (2003) Discovering compact and highly discriminative features or feature combinations of drug activities using support vector machines, IEEE Computer Society Bioinformatics Conference (CSB'03), pp 220-228, Stanford, California.
29. Guyon, I., Weston, J., Barnhill, S., and Vapnik, V. (2002) Gene selection for cancer classification using support vector machines. Machine Learn. 46, 389-422.
30. Xue, Y., Li, Z. R., Yap, C. W., Sun, L. Z., Chen, X., and Chen, Y. Z. (2004) Effect of molecular descriptor feature selection in support vector machine classification of pharmacokinetic and toxicological properties of chemical agents. J. Chem. Inf. Comput. Sci. 44, 1630-1638.
31. Trotter, M. W. B., and Holden, S. B. (2003) Support vector machines for ADME property classification. QSAR Comb. Sci. 22, 533-548.
32. Snyder, R. D., and Green, J. W. (2001) A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res./Rev. Mutat. Res. 488, 151-169.
33. Quillardet, P. H. M. (1993) The SOS chromotest: A review. Mutat. Res. 297, 235-279.
34. Vasilieva, S. (2002) SOS Chromotest methodology for fundamental genetic research. Res. Microbiol. 153, 435-440.
35. Pearlman, R. S. CONCORD User's Manual, Tripos, St. Louis, MO.
36. Dewar, M. J. S., Zoebisch, E. G., Healy, E. F., and Steward, J. P. P. (1985) AMI: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107, 3902-3909.
37. Todeschini, R., and Consonni, V. (2000) Handbook of Molecular Descriptors, Wiley-VCH, Weinheim.
38. Katritzky, A. R., and Gordeeva, E. V. (1993) Traditional topological indices vs electronic, geometrical and combined molecular descriptors in QSAR/QSPR research. J. Chem. Inf. Comput. Sci. 33, 835-857.
39. Cruciani, G., Pastor, M., and Guba, W. (2000) VolSurf: A new tool for the pharmacokinetic optimization of lead compounds. Eur. J. Pharm. Sci. 11, S29-S39.
40. Kier, L. B., and Hall, L. H. (1999) Molecular Structure Description: The Electrotopological State, Academic Press, San Diego.
41. Karelson, M., Lobanov, V. S., and Katritzky, A. R. (1996) Quantum-chemical descriptors in QSAR/QSPR studies. Chem. Rev. 96, 1027-1043.
42. Degroeve, S., De Baets, B., Van de Peer, Y., and Rouzé, P. (2002) Feature subset selection for splice site prediction. Bioinformatics 18, S75-S83.
43. Bayada, D. M., Hamersma, H., and van Geerestein, V. J. (1999) Molecular diversity and representativity in chemical databases. J. Chem. Inf. Comput. Sci. 39, 1-10.
44. Furlanello, C., Serafmi, M., Merler, S., and Jurman, G. (2003) An accelerated procedure for recursive feature ranking on microarray data. Neural Networks 16, 641-648.
45. Vapnik, V. N. (1995) The Nature of Statistical Learning Theory, Springer, New York.
46. Fix, E., and Hodges, J. L. (1951) Discriminatory Analysis: Nonparametric Discrimination: Consistency Properties, USAF School of Aviation Medicine, Randolph Field, Texas.
47. Parzen, E. (1962) On estimation of a probability density function and mode. Ann. Math. Stat. 33, 1065-1076.
48. Cacoullos, T. (1966) Estimation of a multivariate density. Ann. I. Stat. Math. 18, 179-189.
49. Carnahan, B., Meyer, G., and Kuntz, L.-A. (2003) Comparing statistical and machine learning classifiers: Alternatives for predictive modeling in human factors research. Hum. Factors 45, 408-423.
50. Baldi, P., Brunak, S., Chauvin, Y., Andersen, C. A., and Nielsen, H. (2000) Assessing the accuracy of prediction algorithms for classification: An overview. Bioinformatics 16, 412-424.
51. Roulston, J. E. (2002) Screening with tumor markers. Mol. Pharmacol. 20, 153-162.
52. Matthews, B. W. (1975) Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim. Biophys. Acta 405, 442-451.
53. Brown, M. P. S., Grundy, W. N., Lin, D., Cristianini, N., Sugnet, C., Furey, T. S., Manuel Ares, J., and Haussler, D. (2000) Knowledge-based analysis of microarray gene expression data using support vector machines. Proc. Natl. Acad. Sci. U.S.A. 97, 262-267.
54. Huang, C., Davis, L. S., and Townshend, J. R. G. (2002) An assessment of support vector machines for land cover classification. Int. J. Remote Sensing 23, 725-749.
55. Weston, J., Mukherjee, S., Chapelle, O., Pontil, M., Poggio, T., and Vapnik, V. (2001) Feature selection for SVMs, Advances in Neural Information Processing Systems.
56. Saeys, Y., Degroeve, S., Aeyels, D., Rouzé, P., and Van de Peer, Y. (2004) Feature selection for splice site prediction: A new method using EDA-based feature ranking. BMC Bioinformatics 5, 64.
57. Crivori, P., Cruciani, G., Carrupt, P. A., and Testa, B. (2000) Predicting blood-brain barrier permeation from three-dimensional molecular structure. J. Med. Chem. 43, 2204-2216.
58. Chung, K. T., Kirkovsky, L., Kirkovsky, A., and Purcell, W. P. (1997) Review of mutagenicity of monocyclic aromatic amines: Quantitative structure-activity relationships. Mutat. Res. 387, 1-16.
59. Ashby, J. (1985) Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. Environ. Mutagen. 7, 919-921.
60. Wegner, J. K., Fröhlich, H., and Zell, A. (2004) Feature selection for descriptor based classification models. 2. Human intestinal absorption (HIA). J. Chem. Inf. Comput. Sci. 44, 931-939.
61. Luco, J. M. (1999) Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling. J. Chem. Inf. Comput. Sci. 39, 396-404.
62. Basak, S. C., Gute, B. D., and Ghatak S. (1999) Prediction of complement-inhibitory activity of benzamidines using topological, and geometric parameters. J. Chem. Inf. Comput. Sci. 39, 255-260.
63. Chapelle, O., Vapnik, V., Bousquet, O., and Mukherjee, S. (2002) Choosing multiple parameters for support vector machines. Machine Learn. 46, 131-159.